CareDx CDNA
NASDAQ CDNA
$52.40 +1.44 (+2.83%)
As of: Aug 27, 2026 · 3:59 PM EDT

CareDx (CDNA) Restructuring Costs (2023 - 2024)

CareDx (CDNA) posted Restructuring Costs of $1.7 million for Q4 2024, up 2422.06% sequentially from $68000.0 in Q2 2024, and up 16.51% YoY from $1.5 million in Q1 2024.

CareDx (CDNA) Restructuring Costs (2023 - 2024) Analysis & Trends

CareDx has reported Restructuring Costs for 2 years, with the latest figure at $1.7 million in Q4 2024.

  • Quarterly Restructuring Costs rose 16.51% year-over-year to $1.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.3 million (up 40.3% YoY) and the FY2024 annual result came in at $1.8 million, down 23.15% from the prior year.
  • Restructuring Costs climbed to $1.7 million in Q4 2024 per CDNA's latest filing, from $68000.0 in the prior quarter.
  • Over five years, Restructuring Costs peaked at $1.7 million in Q4 2024 and troughed at $68000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 CareDx 2.69 Bn 2.31 Bn 116.03 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 1.72 Mn
Jun 30, 2024 68,000.00
Dec 31, 2023 1.47 Mn
Jun 30, 2023 848,000.00